Sectra is first in the world with product to revolutionize mammography

Invitation to press conference Sectra is first in the world with product to revolutionize mammography Sectra plans clinical trials at Swedish hospitals of a new product that can radically reduce the risks inherent in mammography. Program: Torbjörn Kronander, President Sectra Imtec, presents the product. Mats Danielsson, Associate Professor of Particle Physics, who was involved in developing the technology, explains the product. Ingvar Andersson, Chief Senior Physician and mammography expert, comments on significance for women in Western Europe and USA and for Sweden as a pioneering country within mammography. Time and place: Thursday, November 2, 11:00 a.m., Royal Swedish Academy of Engineering Science (IVA), Grev Turegatan 16, Stockholm. Presentation from 11:00 to 11:20 a.m., followed by an open forum for questions and answers and time for private interviews. You are cordially invited. Torbjörn Kronander The presentation will be in Swedish, but if there is interest, a presentation will be arranged thereafter in English. A press release on the product is available in English and German. If you have any questions regarding the press conference and for notification to attend, please contact Helena Wälivaara, +46 708 23 92 84. Sectra's operations Sectra has its roots in Linköping Technical University and is one of Sweden's fastest growing high-tech companies in the IT area. Since the mid-1980s, Sectra has successfully conducted development and sales of high-technology medical IT and telecommunications products. Today, the business includes products in medical imaging systems, secure communication systems and wireless information systems. Sectra's medical image business is conducted in Sectra Imtec AB, which is a wholly-owned subsidiary of Sectra AB. Internationally, Sectra PACS is marketed and sold through different partners. Business is conducted in six countries with a total of 170 employees. Sales for the fiscal year May 1999-April 2000 reached SEK 192 million. Since March 1999, Sectra's shares have been quoted on the O list of the OM Stockholm Exchange. ------------------------------------------------------------ This information was brought to you by BIT The following files are available for download:

About Us

Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society’s most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2019/2020 fiscal year totaled SEK 1,661 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit